Eisai remains deeply committed to a patient-centered approach in Alzheimer's care and ensuring LEQEMBI (R) is available to those eligible and living with early AD in Canada. We will continue to pursue ...

A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their ...

A major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against ...

Researchers from the NeuroAD group (Neuropathology of Alzheimer's Disease) within the Department of Cell Biology, Genetics ...

Antihypertensives that stimulate angiotensin II receptors are associated with a lower risk for biomarkers of dementia.

To prevent algorithmic bias, the authors call for multivariable modeling frameworks that jointly incorporate biological sex, genetic ancestry, and gender-related life-course exposures.

Mandara Biopharma Inc. announced approval from the FDA to initiate their clinical trials for the treatment of agitation ...

The drug that helps you stand at attention could also help keep your attention. In the hunt to ward off dementia, research out of the UK this week looked to assess whether existing drugs could be ...

A new study seems almost too good to be true: Drinking coffee may help prevent dementia. As a coffee drinker myself, I was ...

The technique is not yet precise enough to predict a patient’s exact trajectory but could help find long-sought preventive treatment.

The Alzheimer’s ‘clock’ could make it easier to treat the disease early, before memory problems appear. A simple blood test might one day serve as a molecular ‘clock’ that predicts not only whether ...

A new Alzheimer's treatment side effect that results in brain swelling may have an upside, according to a new study from Houston Methodist Research Institute. The research finds that beta amyloid—a ...